Healthcare provider profile · identity verified

Miranda J. Turner, M.D.

Family Practice · LEWISVILLE, NC · NPI 1598071797

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	454	124
Lisinopril	Lisinopril	258	73
Hydrochlorothiazide	Hydrochlorothiazide	238	73
Losartan Potassium	Losartan Potassium	197	61
Rosuvastatin Calcium	Rosuvastatin Calcium	197	66
Amlodipine Besylate	Amlodipine Besylate	186	55
Levothyroxine Sodium	Levothyroxine Sodium	186	54
Omeprazole	Omeprazole	130	36
Simvastatin	Simvastatin	106	29
Albuterol Sulfate Hfa	Albuterol Sulfate	99	29
Gabapentin	Gabapentin	99	33
Metformin Hcl	Metformin Hcl	97	27
Metoprolol Succinate	Metoprolol Succinate	96	27
Pravastatin Sodium	Pravastatin Sodium	89	28
Eliquis	Apixaban	82	15
Tamsulosin Hcl	Tamsulosin Hcl	82	26
Citalopram Hbr	Citalopram Hydrobromide	70	16
Montelukast Sodium	Montelukast Sodium	67	17
Allopurinol	Allopurinol	66	18
Pantoprazole Sodium	Pantoprazole Sodium	66	20
Duloxetine Hcl	Duloxetine Hcl	64	18
Metformin Hcl Er	Metformin Hcl	64	19
Furosemide	Furosemide	59	16
Mirtazapine	Mirtazapine	59	16
Bupropion Xl	Bupropion Hcl	58	15
Trazodone Hcl	Trazodone Hcl	55	16
Fluoxetine Hcl	Fluoxetine Hcl	54	13
Sertraline Hcl	Sertraline Hcl	46	14
Fluticasone Propionate	Fluticasone Propionate	44	21
Ozempic	Semaglutide	42	16
Symbicort	Budesonide/Formoterol Fumarate	41	suppressed
Meloxicam	Meloxicam	39	13
Propranolol Hcl Er	Propranolol Hcl	39	suppressed
Carvedilol	Carvedilol	37	13
Escitalopram Oxalate	Escitalopram Oxalate	35	11
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	35	suppressed
Warfarin Sodium	Warfarin Sodium	35	11
Diclofenac Sodium	Diclofenac Sodium	33	16
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	32	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	30	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	29	14
Tizanidine Hcl	Tizanidine Hcl	28	suppressed
Clopidogrel	Clopidogrel Bisulfate	27	suppressed
Ezetimibe	Ezetimibe	26	suppressed
Azelastine Hcl	Azelastine Hcl	24	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	24	suppressed
Trulicity	Dulaglutide	24	suppressed
Soliqua 100-33	Insulin Glargine/Lixisenatide	23	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	23	suppressed
Chlorthalidone	Chlorthalidone	20	suppressed
Atenolol	Atenolol	19	suppressed
Finasteride	Finasteride	19	suppressed
Ipratropium Bromide	Ipratropium Bromide	19	suppressed
Januvia	Sitagliptin Phosphate	19	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	19	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	19	suppressed
Jardiance	Empagliflozin	18	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	18	16
Benazepril Hcl	Benazepril Hcl	17	suppressed
Donepezil Hcl	Donepezil Hcl	17	suppressed
Buspirone Hcl	Buspirone Hcl	16	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	16	suppressed
Glipizide Er	Glipizide	16	suppressed
Terazosin Hcl	Terazosin Hcl	16	suppressed
Ventolin Hfa	Albuterol Sulfate	16	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	15	12
Mounjaro	Tirzepatide	15	suppressed
Paroxetine Hcl	Paroxetine Hcl	15	suppressed
Torsemide	Torsemide	15	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	14	suppressed
Farxiga	Dapagliflozin Propanediol	14	suppressed
Klor-Con M20	Potassium Chloride	14	suppressed
Ondansetron Odt	Ondansetron	14	suppressed
Spiriva Respimat	Tiotropium Bromide	14	suppressed
Lovastatin	Lovastatin	13	suppressed
Potassium Chloride	Potassium Chloride	13	suppressed
Prednisone	Prednisone	13	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	13	11
Xarelto	Rivaroxaban	13	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	12	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	12	suppressed
Synthroid	Levothyroxine Sodium	12	suppressed
Telmisartan	Telmisartan	12	suppressed
Valsartan	Valsartan	12	suppressed
Glipizide	Glipizide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error